단일 기관에서의 소아 혈액종양 환자에서 발생한 균혈증의 원인균 및 임상 양상: 2011–2015년
Etiology of Bacteremia in Children with Hemato-oncologic Diseases from a Single Center from 2011 to 2015
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
목적: 2011년부터 2015년까지 최근 5년간 서울대학교 어린이병원 소아 혈액종양 환자에게 발생한 균혈증의 원인균 분포와 이들의 항생제감수성을 분석하여 경험적 항생제 선택에 실제적인 도움을 얻고자하였으며 원인균의 분포와 항생제감수성에서 이전 연구와 경향성을 비교하고자 하였다. 방법: 2011년부터 2015년 12월까지 서울대학교 어린이병원에서 입원 치료를 받은 소아 혈액종양 환자들에게 발생한 균혈증에 대하여 의무기록을 후향적으로 분석하였다. 결과: 총 167명의 소아 종양 환자에게 221예의 균혈증이 발생하였고, 229 균주가 분리되었다. 이 중그람음성균, 그람양성균, 진균이 각각 69.0% (2002–2005년 64.0%, 2006–2010년 63.4%), 28.8% (2002–2005년 31.3%, 2006–2010년 34.6%), 2.2% (2002–2005년 4.7%, 2006–2010년 2.0%) 의 분포를 보였다. 그람음성균 중에는 Klebsiella species (53.2%, 84/158), Escherichia coli (19.6%, 31/158), 그람양성균 중에는 Staphylococcus aureus (48.5%, 32/66), viridans streptococci (21.2%, 14/66)가 높은 비율로 분리되었다. 그람양성균의 페니실린, 옥사실린, 반코마이신 감수성률은 각각 13.8%, 54.8%, 96.9% (2002–2005년 16.7%, 51.5%, 95.5%; 2006–2010년 14.3%, 34.1%, 90.5%)이었고, 그람음성균의 세포탁심(cefotaxime), 피페라실린/타조박탐(piperacillin/ tazobactam), 이미페넴(imipenem), 겐타마이신(gentamicin), 아미카신(amikacin) 감수성률은 각각 73.2%, 77.2%, 92.6%, 71.0%, 95.2% (2002–2005년 75.9%, 82.8%, 93.4%, 78.4%, 85.8%; 2006–2010년 62.8%, 82.9%, 93.8%, 67.8%, 86.3%)이었다. 본 연구의 원인균 분포 및 항생제감수성률은 과거 연구와 비교하여 차이가 없었다. 전체 환자에서 치사율은 13.1%이었다. 결론: 그람음성균은 소아 혈액종양 환자의 균혈증의 가장 흔한 원인균이다. 균혈증의 원인균과 항생제감수성은 이전 연구들과 다르지 않았다. 연구 결과에 따라 본 연구 기관에서는 예년과 같이 발열을 동반하는 소아 혈액종양 환자에서의 경험적 항생제를 피페라실린/타조박탐으로 투여할 수 있을 것이다.
Abstract
Purpose: The aim of this study was to identify the pathogens of blood stream infection (BSI) in children with hemato-oncologic disorders, to analyze susceptibility patterns of microorganisms to guide empirical antimicrobial therapy, and to compare temporal trends of the pathogen and antimicrobial susceptibility with those of previous studies. Methods: We retrospectively analyzed the medical records of children with hemato-oncologic disorders whose blood culture grew pathogens at the Seoul National University Children’s Hospital between 2011 and 2015. Results: A total of 167 patients developed 221 episodes of bacteremia. Among 229 pathogens, gram-negative bacteria (GNB) accounted for 69.0% (64.0% in 2002 to 2005, 63.4% in 2006 to 2010); gram-positive bacteria (GPB) accounted for 28.8% (31.3% in 2002 to 2005, 34.6% in 2006 to 2010); and fungus accounted for 2.2%. Among GNB, Klebsiella species (53.2%, 84/158) and Escherichia coli (19.6%, 31/ 158) were common. Staphylococcus aureus (48.5%, 32/66) and viridans streptococci (21.2%, 14/66) were frequently isolated among GPB. The susceptibilities of oxacillin and vancomycin in GPB were 54.8% and 96.9% (51.5% and 95.5% in 2002 to 2005; 34.1% and 90.5% in 2006 to 2010), respectively, whereas in GNB, the susceptibilities of cefotaxime, piperacillin/tazobactam, and imipenem were 73.2%, 77.2%, and 92.6% (75.9%, 82.8%, and 93.4% in 2002 to 2005; 62.8%, 82.9%, 93.8% and in 2006 to 2010), respectively. There were no significant differences in the proportion of etiologic agents or the antimicrobial susceptibilities between the current study and that of the previous two studies from 2002 to 2010. Overall fatality rate was 13.1%. Conclusions: GNB predominated in BSI among children with hemato-oncologic disorders. The etiology of bacteremia and antimicrobial susceptibility were comparable to those of the previous studies. Thus, piperacillin/tazobactam can be used as the initial empirical antimicrobial agent in febrile neutropenia.
참고문헌 (21)
- Viscoli C, "Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification", Clin Infect Dis, 40(Suppl 4), pp.S240~S245 (2005)
- Pizzo PA, "Management of fever in patients with cancer and treatment-induced neutropenia", N Engl J Med, 328, pp.1323~1332 (1993)
- Klastersky J, "Bacteraemia in febrile neutropenic cancer patients", Int J Antimicrob Agents, 30(Suppl 1), pp.S51~S59 (2007)
- Norgaard M, "Risk of bacteraemia and mortality in patients with haematological malignancies", Clin Microbiol Infect, 12, pp.217~223 (2006)
- Aust C, "Bacteremia in Swedish hematological patients with febrile neutropenia : bacterial spectrum and antimicrobial resistance patterns", Scand J Infect Dis, 45, pp.285~291 (2013)
- Singer C, "Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases", Am J Med, 62, pp.731~742 (1977)
- Zinner SH, "Changing epidemiology of infections in patients with neutropenia and cancer : emphasis on gram-positive and resistant bacteria", Clin Infect Dis, 29, pp.490~494 (1999)
- Wisplinghoff H, "Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States", Clin Infect Dis, 36, pp.1103~1110 (2003)
- Ramphal R., "Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens", Clin Infect Dis, 39(Suppl 1), pp.S25~S31 (2004)
- Gudiol C, "Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients", Clin Microbiol Infect, 19, pp.474~479 (2013)
- Elting LS, "Septicemia and shock syndrome due to viridans streptococci : a case-control study of predisposing factors", Clin Infect Dis, 14, pp.1201~1207 (1992)
- Cordonnier C, "Epidemiology and risk factors for grampositive coccal infections in neutropenia : toward a more targeted antibiotic strategy", Clin Infect Dis, 36, pp.149~158 (2003)
- 김소희, "소아 혈액 종양 환자에서 발생한 균혈증의 원인균(2002-2005년)", Korean Journal of Pediatrics, 50(1), pp.56~64 (2007), 대한소아과학회
- 강지은, "최근 5년(2006-2010)간 소아 혈액 종양 환자에서 발생한 균혈증의 원인균 및 임상 양상: 단일기관 연구", Pediatric Infection and Vaccine, 19(3), pp.131~140 (2012), 대한소아감염학회
- Mermel LA, "Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection : 2009Update by the Infectious Diseases Society of America", Clin Infect Dis, 49, pp.1~45 (2009)
- Kleinman ME, "Pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care", Pediatrics, 126, pp.e1361~e1399 (2010)
- Maki DG, "The efficacy of a chlorhexidine-impregnated sponge (biopatch) for the prevention of intravascular catheter-related infection: a prospective, randomized, controlled, multicenter study", Present at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (2000)
- Levy I, "Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children : a randomized controlled study", Pediatr Infect Dis J, 24, pp.676~679 (2005)
- Ho KM, "Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection : a meta-analysis", J Antimicrob Chemother, 58, pp.281~287 (2006)
- Rivas-Ruiz R, "Efficacy of a chlorhexidine-gluconate impregnated patch for prevention of catheter-related infections in pediatric patients : systematic review and meta-analysis", Bol Med Hosp Infant Mex, 68, pp.349~355 (2011)
- Han SB, "Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia", Infection, 41, pp.917~924 (2013)